BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10442373)

  • 1. Uracil/tegafur plus oral calcium folinate in advanced breast cancer.
    Richardet E; Pedraza C; Mickiewicz E; Lerzo G; Bonamasa M; Coppola F; Elli A; Uranga G; Jovtis S; Bruno M; Ventriglia M; Cuevas MA; Alvarez AM; Suarez LA; Fein L
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):96-7. PubMed ID: 10442373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
    Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.
    Fumoleau P; Déporte-Fety R; Kerbrat P; Laguerre B
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):86-90. PubMed ID: 10442371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
    Lück HJ; Scholz U; Kühnle H; Dethling J
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin, cyclophosphamide, and UFT plus oral calcium folinate in advanced breast cancer.
    Smith IE
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):82-5. PubMed ID: 10442370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer.
    Ravaud A; Borner M; Schellens JH; Geoffrois L; Schöffski P; Wanders J; Hanauske AR
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):61-3. PubMed ID: 10442364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
    Díáz-Rubio E; Sastre J; Abad A; Navarro M; Aranda E; Carrato A; Gallén M; Marcuello E; Rifá J; Massuti T; Cervantes A; Antón A; Fernández Martos C
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):35-40. PubMed ID: 10442357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UFT/calcium folinate plus weekly paclitaxel for solid tumors.
    Bokemeyer C; Hartmann JT; Kollmannsberger C; Mayer F; Kanz L
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):106-11. PubMed ID: 10442376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinoma.
    Hoff PM; Pazdur R
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):48-50. PubMed ID: 10442361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
    Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
    Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer.
    Smith R; Wickerham DL; Wieand HS; Colangelo L; Mamounas EP
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):44-7. PubMed ID: 10442360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel, UFT, and calcium folinate in metastatic breast cancer.
    Dickson NR; Nicholson BP; Hande K; Blanke C; Johnson D; Cohen A
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):69-70. PubMed ID: 10442366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.
    Scholz U; Lück HJ; Canzler U; Robner D; Kühnle H
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):44-6. PubMed ID: 11098492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.
    Hoff PM; Lassere Y; Pazdur R
    Drugs; 1999; 58 Suppl 3():77-83. PubMed ID: 10711845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UFT/oral calcium folinate plus radiation in pancreatic cancer.
    Robert F; Raben D; Spencer S
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):127-8. PubMed ID: 10442381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
    Gregory RK; Johnston SR; Smith IE; Miles D
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):47-9. PubMed ID: 11098493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UFT in the treatment of colorectal and breast cancer.
    Sun W; Haller D
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):49-56. PubMed ID: 11219978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer.
    Ichikura T; Tomimatsu S; Okusa Y; Yahara T; Uefuji K; Tamakuma S
    Cancer Chemother Pharmacol; 1996; 38(5):401-5. PubMed ID: 8765432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.